The German pharmaceutical company has tied up with professional services firm Genpact for the work, signing a multi-year agreement for its Pharmacovigilance Artificial Intelligence (PVAI ...
Pharmacovigilance Market Expected To Achieve A Strong 8.62% CAGR, To Reach USD 17.95 Billion By 2034
Significant investments in pharmacovigilance research and infrastructure. South America: A developing market with rising healthcare awareness, increasing access to medications, and growing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results